ask="56.02"
ask_size="100"
average_daily_volume="1081340"
bid="37.50"
bid_size="100"
book_value="3.62"
change="+1.29"
change_from_200_day_moving_average="-0.86"
change_from_50_day_moving_average="2.05"
change_from_52_week_high="-10.37"
change_From_52_week_low="12.43"
change_in_percent="+2.97%"
close="44.78"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.63"
ebitda="-145.92M"
eps_estimate_current_year="-2.34"
eps_estimate_next_quarter="-0.63"
eps_estimate_next_year="-1.30"
ex_dividend_date="N/A"
float_shares="85906000"
high="45.13"
high_52_weeks="55.15"
last_trade_date="3/8/2017"
last_trade_price="44.78"
last_trade_size="33048"
last_trade_time="4:00pm"
low="43.48"
low_52_weeks="32.35"
market_capitalization="3.90B"
moving_average_200_day="45.64"
moving_average_50_day="42.73"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="67.67"
open="43.67"
pe_ratio="N/A"
peg_ratio="0.51"
percent_change_from_200_day_moving_average="-1.89%"
percent_change_from_50_day_moving_average="+4.80%"
percent_change_from_52_week_high="-18.80%"
percent_change_from_52_week_low="+38.42%"
previous_close="43.49"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="12.00"
price_per_sales="252.57"
revenue="15.00M"
shares_outstanding="87114000"
short_ratio="3.47"
stock_exchange="NMS"
symbol="NBIX"
volume="848913"
weeks_range_52="32.35 - 55.15"
